AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

amoxicillin trihydrate, Quantity: 574 mg (Equivalent: amoxicillin, Qty 500 mg); potassium clavulanate, Quantity: 148.9 mg (Equivalent: clavulanic acid, Qty 125 mg)

Available from:

Southern Cross Pharma Pty Ltd

INN (International Name):

amoxicillin trihydrate,potassium clavulanate

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; methylcellulose; dimeticone 100; colloidal anhydrous silica; purified talc; magnesium stearate; titanium dioxide; sodium starch glycollate; diethyl phthalate

Administration route:

Oral

Units in package:

10 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Amoxicillin and clavulanic acid tablets are indicated for short-term treatment of bacterial infections at the following sites when caused by sensitive organisms: - Urinary tract infections (uncomplicated and complicated). - Lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis. - Upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis. - Skin and skin structure infections. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Amoxyclave Duo SCP and Amoxyclave Duo Forte SCP tablets. However, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in Microbiology, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Amoxyclave Duo SCP and Amoxyclave Duo Forte Scp tablets should not require the addition of another antibiotic due to the amoxycillin content of these products.

Product summary:

Visual Identification: White convex capsule shaped film coated tablet; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-07-12